文献速递传染病防控与疫情报告

产OXA-48的ST-22弗氏柠檬酸杆菌在患者和医院环境中的持续存在:法国巴黎,2016至2022年

Persistence of OXA-48-producing ST-22 Citrobacter freundii in patients and the hospital environment, Paris, France, 2016 to 2022.
PubMed 文献 · Euro Surveill · 2024-01-01

2016至2019年,A医院血液科病房发生产OXA-48的ST-22弗氏柠檬酸杆菌暴发,厕所被确定为传播来源。2020至2022年,其他病房分离出28株产OXA-48的ST-22弗氏柠檬酸杆菌。本研究旨在通过全基因组测序确定所有产OXA-48的ST-22弗氏柠檬酸杆菌是否属于同一克隆并调查该克隆的持续存在。

要点

  • 2016至2019年A医院血液科病房发生产OXA-48的ST-22弗氏柠檬酸杆菌暴发,厕所为传播来源。
  • 2020至2022年其他病房分离出28株产OXA-48的ST-22弗氏柠檬酸杆菌。
  • 对来自7个病房患者(n=33)和医院环境(n=20)的菌株进行测序分析。

核心结论

  • 数据提示该克隆可在医院环境中持续存在数年,对医院获得性感染和暴发构成风险。
  • 储库管理对防止进一步传播至关重要。

研究设计与样本

  • 对A医院7个病房患者(n=33)和医院环境(n=20)收集的产OXA-48的ST-22弗氏柠檬酸杆菌菌株使用Illumina技术测序。
  • 采用单核苷酸多态性(SNP)确定克隆关系。
  • 对A医院的53株菌株和法国其他地方分离的240株流行病学无关的碳青霉烯耐药ST-22弗氏柠檬酸杆菌进行系统发育分析。

主要发现

  • SNP分析提示同一克隆持续存在超过6年。
  • 系统发育分析显示,A医院分离的53株菌株中52株属于同一簇,且与240株流行病学无关的ST-22弗氏柠檬酸杆菌不同。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 2016-2019, hospital A's haematology ward experienced an outbreak of OXA-48-producing ST-22 Citrobacter freundii strains, with toilets identified as source of transmission. Between 2020 and 2022, 28 strains of OXA-48-producing ST-22 C. freundii were isolated on other wards. This study aimed to determine whether all OXA-48-producing ST-22 C. freundii strains belonged to the same clone and to investigate the persistence of this clone using whole genome sequencing. OXA-48-producing ST-22 C. freundii strains collected from patients (n = 33) and from the hospital environment (n = 20) of seven wards were sequenced using Illumina technology and clonal relationships were determined using single nucleotide polymorphism (SNP). Phylogenetic analyses were performed on 53 strains from hospital A and on 240 epidemiologically unrelated carbapenem-resistant ST-22 C. freundii isolated from elsewhere in France. SNP analysis suggested long-lasting persistence of the same clone for more than 6 years. Phylogenetic analysis showed that 52 of 53 strains isolated in hospital A belonged to the same cluster and were different from the 240 epidemiologically unrelated C. freundii ST-22. Our data suggest that this clone can persist in hospital environments for years, representing a risk for hospital-acquired infections and outbreaks. Reservoir management is essential to prevent further transmission.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Jolivet S, Couturier J, Le Neindre K, et al. Persistence of OXA-48-producing ST-22 Citrobacter freundii in patients and the hospital environment, Paris, France, 2016 to 2022. Euro Surveill. 2024. PMID: 39639813. doi:10.2807/1560-7917.ES.2024.29.49.2400262

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。